RESEARCH STUDYFOR GLAUCOMA OR OCULAR HYPERTENSION
See the Beauty all around you.
We want to help protect the vision of people with glaucoma and ocular hypertension.
We are recruiting people with glaucoma or ocular hypertension to take part in the Esther clinical study. This study may be the first clinical study you’ve heard of, but they are more common than you think. Tens of thousands of studies take place every year. These studies are monitored very closely to make sure the rights, safety and wellbeing of study patients are protected.
What is the Esther study?
The Esther study will compare an investigational preservative-free eyedrop with a preserved treatment alternative currently available. These eyedrops are used to reduce eye (intraocular) pressure, to help protect the vision and quality of life for people with glaucoma or ocular hypertension.
Both eyedrop solutions being compared contain the same active ingredient, called bimatoprost, so your glaucoma or ocular hypertension will continue to be treated during the study.
The Esther study will last for up to 18 weeks and is designed to have minimum impact on your daily life with only five visits to a study doctor at the clinic site. Treatment, eye exams and appointments will be provided free of charge.
Complete the form today to get in touch with the study team.